ELMSFORD, N.Y., Feb. 3, 2014 /PRNewswire/
-- BioScrip®, Inc. (NASDAQ: BIOS), today announced
its proposal to commence an offering through a private placement,
subject to market and other conditions, of $200 million in aggregate principal amount of
senior notes due 2021. The notes will be senior unsecured
obligations of BioScrip and will be guaranteed by certain of
BioScrip's subsidiaries.
BioScrip intends to use the net proceeds of the offering to pay
a portion of the amounts outstanding on its $75 million senior
secured first-lien revolving credit facility, its $150 million senior secured first-lien delayed
draw term B loan and its $250 million
senior secured first-lien term loan B.
The notes and related guarantees are being offered in a private
placement, solely to qualified institutional buyers in reliance on
Rule 144A under the Securities Act of 1933, as amended (the
"Securities Act"), or outside the United
States to persons other than "U.S. persons" in compliance
with Regulation S under the Securities Act. The notes and related
guarantees have not been registered under the Securities Act or the
securities laws of any other jurisdiction and may not be offered or
sold in the United States absent
registration or an applicable exemption from the registration
requirements.
This notice does not constitute an offer to sell the notes, nor
a solicitation for an offer to purchase the notes, in any
jurisdiction in which such offer or solicitation would be unlawful.
Any offer of the notes will be made only by means of a private
offering memorandum. This press release is being issued pursuant to
and in accordance with Rule 135c under the Securities Act.
About BioScrip, Inc.
BioScrip, Inc. provides comprehensive infusion and home care
solutions. By partnering with patients, physicians, healthcare
payors, government agencies and pharmaceutical manufacturers, we
are able to provide access to infusible medications and management
solutions. Our goal is to optimize outcomes for chronic and other
complex healthcare conditions and enhance the quality of patient
life. BioScrip brings clinical competence in providing high-touch,
comprehensive infusion and nursing services to patients in the most
convenient ways possible. Through our customer services and
treatments we aim to ensure the best possible therapy
outcome.
Contacts:
Hai Tran
BioScrip, Inc.
952-979-3768
SOURCE BioScrip, Inc.